Polycaprolactone nanofibers as an adjuvant strategy for Tamoxifen release and their cytotoxicity on breast cancer cells

Agricultura y biología

• tamoxifen 98%
• nanofibers 87%
• breast neoplasms 82%
• adjuvants 75%
• citrates 69%
• neoplasm cells 65%
• cytotoxicity 61%
• drug delivery systems 11%
• hormone receptors 10%
• biocompatible materials 8%
• extracellular matrix 8%
• in vitro studies 7%
• death 6%
• cell lines 5%
• drugs 5%
• assays 4%
• tissues 3%
• testing 3%
• methodology 2%

Compuestos químicos

• Tamoxifen Citrate 100%
• Tamoxifen 97%
• Adjuvant 88%
• Nanofiber 61%
• Resazurin 13%
• Hormone 8%
• Antitumor 8%
• Biomaterial 7%
• Drug 4%
• Reduction 4%

Medicina y ciencias biológicas

• Nanofibers 93%
• polycaprolactone 91%
• Tamoxifen 76%
• Breast Neoplasms 45%
• resazurin 11%
• Biocompatible Materials 8%
• Drug Delivery Systems 7%
• Extracellular Matrix 6%
• Cause of Death 6%
• Hormones 5%
• Therapeutics 5%
• Equipment and Supplies 4%
• Cell Line 4%
• In Vitro Techniques 3%
• Pharmaceutical Preparations 3%